| Electrodiagnostic criteria for diagnosis of ALS M De Carvalho, R Dengler, A Eisen, JD England, R Kaji, J Kimura, K Mills, ... Clinical neurophysiology 119 (3), 497-503, 2008 | 1335 | 2008 |
| Fundamentals of sensation and perception MW Levine, JM Shefner | 572 | 1991 |
| A revision of the El Escorial criteria-2015 A Ludolph, V Drory, O Hardiman, I Nakano, J Ravits, W Robberecht, ... Amyotrophic lateral sclerosis and frontotemporal degeneration 16 (5-6), 291-292, 2015 | 498 | 2015 |
| Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, ... New England Journal of Medicine 383 (10), 919-930, 2020 | 472 | 2020 |
| A collagen‐based nerve guide conduit for peripheral nerve repair: An electrophysiological study of nerve regeneration in rodents and nonhuman primates SJ Archibald, C Krarup, J Shefner, ST Li, RD Madison Journal of Comparative Neurology 306 (4), 685-696, 1991 | 466 | 1991 |
| Monkey median nerve repaired by nerve graft or collagen nerve guide tube SJ Archibald, J Shefner, C Krarup, RD Madison Journal of Neuroscience 15 (5), 4109-4123, 1995 | 463 | 1995 |
| A proposal for new diagnostic criteria for ALS JM Shefner, A Al-Chalabi, MR Baker, LY Cui, M de Carvalho, A Eisen, ... Clinical Neurophysiology 131 (8), 2020 | 408 | 2020 |
| A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis ALS CNTF Treatment Study Group Neurology 46 (5), 1244-1244, 1996 | 375 | 1996 |
| Recovery from paralysis in adult rats using embryonic stem cells DM Deshpande, YS Kim, T Martinez, J Carmen, S Dike, I Shats, LL Rubin, ... Annals of neurology 60 (1), 32-44, 2006 | 344 | 2006 |
| A clinical trial of creatine in ALS JM Shefner, ME Cudkowicz, D Schoenfeld, T Conrad, J Taft, M Chilton, ... Neurology 63 (9), 1656-1661, 2004 | 341 | 2004 |
| A controlled trial of recombinant methionyl human BDNF in ALS BDNF Study Group (Phase III) Neurology 52 (7), 1427-1427, 1999 | 340* | 1999 |
| Trial of celecoxib in amyotrophic lateral sclerosis ME Cudkowicz, JM Shefner, DA Schoenfeld, H Zhang, KI Andreasson, ... Annals of neurology 60 (1), 22-31, 2006 | 339 | 2006 |
| Nusinersen in later-onset spinal muscular atrophy: long-term results from the phase 1/2 studies BT Darras, CA Chiriboga, ST Iannaccone, KJ Swoboda, J Montes, ... Neurology 92 (21), e2492-e2506, 2019 | 269 | 2019 |
| Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III P Kaufmann, JLP Thompson, G Levy, R Buchsbaum, J Shefner, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 265 | 2009 |
| Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial ME Cudkowicz, LH van den Berg, JM Shefner, H Mitsumoto, JS Mora, ... The Lancet Neurology 12 (11), 1059-1067, 2013 | 260 | 2013 |
| A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis ME Cudkowicz, JM Shefner, DA Schoenfeld, RH Brown Jr, H Johnson, ... Neurology 61 (4), 456-464, 2003 | 256 | 2003 |
| Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial ME Cudkowicz, S Titus, M Kearney, H Yu, A Sherman, D Schoenfeld, ... The Lancet Neurology 13 (11), 1083-1091, 2014 | 242 | 2014 |
| Lead exposure and amyotrophic lateral sclerosis F Kamel, DM Umbach, TL Munsat, JM Shefner, H Hu, DP Sandler Epidemiology 13 (3), 311-319, 2002 | 240 | 2002 |
| Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy JM Shefner, AG Reaume, DG Flood, RW Scott, NW Kowall, RJ Ferrante, ... Neurology 53 (6), 1239-1239, 1999 | 236 | 1999 |
| Improving clinical trial outcomes in amyotrophic lateral sclerosis MC Kiernan, S Vucic, K Talbot, CJ McDermott, O Hardiman, JM Shefner, ... Nature Reviews Neurology 17 (2), 104-118, 2021 | 230 | 2021 |
